前收市價 | 60.59 |
開市 | 60.85 |
買盤 | 61.09 x 200 |
賣出價 | 61.25 x 200 |
今日波幅 | 60.27 - 62.88 |
52 週波幅 | 20.66 - 66.54 |
成交量 | |
平均成交量 | 422,512 |
市值 | 2.4B |
Beta 值 (5 年,每月) | 1.20 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -1.24 |
業績公佈日 | 2024年8月05日 - 2024年8月09日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 72.43 |
Like its patients, RxSight has 20/20 vision — at least where profitability is concerned. And RxSight stock is approaching another record.
We have narrowed our search to five Medical Instruments stocks with strong potential for 2024. These stocks are: ALC, RXST, HOLX, VCYT, MASI.
RxSight, Inc. (NASDAQ:RXST) Q1 2024 Earnings Call Transcript May 6, 2024 RxSight, Inc. misses on earnings expectations. Reported EPS is $-0.24699 EPS, expectations were $-0.17. RXST isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank you for […]